#financial-results

#financial-results

Colombo moved to Liguria in the summer on loan with an option to buy, reportedly set at €10m. The option to buy became an obligation upon the fulfilment of certain conditions, including 22 appearances, five goals and Genoa's safety, which was mathematically secured.

The company reported first-quarter revenue of $542.13 million, down 2.4% year over year but ahead of the analyst consensus estimate of $540.73 million. Adjusted earnings came in at 8 cents per share, down 84.6% from a year earlier and below analyst estimates of 21 cents. Revenue in the domestic operations segment fell 3.2% year over year to $470.69 million.

Rocket Lab's revenue grew 64 per cent, its stock hit a record high, and its backlog reached 2.2 billion dollars. The company sold more launches in the first quarter of 2026 than in the entire previous year. The only thing that has not launched yet is the rocket the market is pricing in.

BioNTech plans to align and consolidate its manufacturing network further where excess capacity is expected, exploring divestment options for each site, including partial or total sales.

Freddie Mac's net income for the first quarter was $3.6 billion, with net revenues reaching $6.1 billion, largely due to a 10% increase in net interest income to $5.6 billion.

Kambi's Q1 2026 report shows a revenue of 43.5 million and an operating profit of 4.2 million, with EBITDA increasing significantly year-on-year. CEO Werner Becher stated that the quarter reflects a return to growth after a challenging 2025, characterized by major customer migrations.

Fatih Birol, head of the International Energy Agency, described the war in Iran as the biggest energy crisis in history, pointing to major disruptions in commodities, including fuel shortages and rising prices for consumers.

Cleveland-Cliffs reported a Q1 FY2026 adjusted loss of $0.40 per share, which beat the Street's estimate of a loss of $0.416 per share. The progress is real, but it's still a loss, and investors appear unwilling to reward the stock for simply losing less money.

"We are no longer a company in transition. We are a growth company with a proven track record of execution, and we are well positioned for the path ahead."

GoPro will cut 23 percent of its global workforce by the end of this year, as the action camera pioneer looks to reverse its fortunes in a competitive market.

GameStop ended Q4 with $9.01 billion in total cash, equivalents, and marketable securities, nearly double the $4.77 billion held a year prior. That buildup was funded by $4.2 billion in zero-coupon convertible notes issued during fiscal 2025.

Sonoco Products ( NYSE: SON) shares reached a 52-week high of $57.83 this week after strong 2025 results and 2026 guidance. That marks a 30% year-to-date surge that has far outpaced the S&P 500's fractional gain. The packaging company's rally accelerated following the February 17 earnings. With the stock at 52-week highs and technical indicators flashing warning signs, investors face the critical question of whether this momentum is sustainable or the valuation catch-up has run its course.

Medtronic ( NYSE: MDT) delivered its strongest enterprise revenue growth in 10 quarters, posting 8.7% reported growth (6.0% organic) for Q3 fiscal 2026. Cardiac Ablation Drives Outperformance The Cardiovascular Portfolio led the quarter with 13.8% reported growth, powered by an exceptional 80% surge in Cardiac Ablation Solutions. U.S. cardiac ablation revenue exploded 137%, driven by the company's pulsed field ablation (PFA) portfolio. Cardiac Rhythm & Heart Failure revenue reached $1.86 billion, up 17%, while Diabetes posted 8.3% organic growth to $796 million.

Carvana ( NYSE: CVNA) is down 15.1% over the past week, extending a brutal month that has seen shares fall 25.2% since mid-January. Yet Wall Street analysts still see the online used car retailer climbing to an average target of $481.05, implying 40.3% upside from current levels. That gap between price and target is now one of the widest among major consumer stocks,

InterContinental Hotels Group, owner of Holiday Inn, Crowne Plaza, and Hotel Indigo, reported robust revenue and profit growth for 2025, driven by a record hotel rollout and strategic acquisitions. The group opened 443 new hotels over the past year - adding more than 65,000 rooms - and completed its acquisition of the European hotel brand Ruby. Financially, IHG posted total revenue of $5.19 billion (£3.8 billion), up 5% from 2024, while operating profits rose 15% to $1.2 billion (£880 million).